Insmed Gene Therapy Llc
Clinical trials sponsored by Insmed Gene Therapy Llc, explained in plain language.
A subsidiary of Insmed focused on gene therapy for rare diseases.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Spinal gene injection aims to slow duchenne in toddlers
Disease control Recruiting nowThis early-stage study tests a single injection of a gene therapy called INS1201, given into the spinal fluid of young boys (ages 2 to 5) with Duchenne muscular dystrophy who can still walk. The main goal is to check if the treatment is safe and to see how it spreads in the body.…
Phase: PHASE1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Gene therapy injection aimed at slowing ALS enters human testing
Disease control Recruiting nowThis early-stage trial is testing a single injection of a gene therapy called INS1202, given into the spinal fluid, for people with ALS (Lou Gehrig's disease). The study includes 23 adults, some with a specific genetic mutation (SOD1) and some without known genetic causes. The ma…
Phase: PHASE1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC